Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L1044
Description
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | -0.98 | |||||
| Debt-to-Equity | -1.63 | |||||
| Debt-to-EBITDA | -1.37 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -25.43 | |||||
| Beneish M-Score | -4.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.8 | |||||
| 3-Year EBITDA Growth Rate | 41.6 | |||||
| 3-Year EPS without NRI Growth Rate | 42.7 | |||||
| 3-Year FCF Growth Rate | 41.8 | |||||
| 3-Year Book Growth Rate | 46.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.84 | |||||
| 9-Day RSI | 38.63 | |||||
| 14-Day RSI | 42.43 | |||||
| 6-1 Month Momentum % | -26.5 | |||||
| 12-1 Month Momentum % | -93.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 91.74 | |||||
| Days Sales Outstanding | 50.51 | |||||
| Days Payable | 54.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -96.8 | |||||
| Shareholder Yield % | -436.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -41.49 | |||||
| Operating Margin % | -394.32 | |||||
| Net Margin % | -392.26 | |||||
| ROA % | -137.92 | |||||
| ROIC % | -186.54 | |||||
| ROC (Joel Greenblatt) % | -341.49 | |||||
| ROCE % | -327.85 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.15 | |||||
| EV-to-EBIT | -2.81 | |||||
| EV-to-Forward-EBIT | -3.38 | |||||
| EV-to-EBITDA | -2.95 | |||||
| EV-to-Revenue | 9.71 | |||||
| EV-to-Forward-Revenue | 4.62 | |||||
| EV-to-FCF | -2.47 | |||||
| Earnings Yield (Greenblatt) % | -35.59 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TTOO
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.202 | ||
| EPS (TTM) ($) | -5.76 | ||
| Beta | -0.35 | ||
| Volatility % | 208.53 | ||
| 14-Day RSI | 42.43 | ||
| 14-Day ATR ($) | 0.072134 | ||
| 20-Day SMA ($) | 0.30683 | ||
| 12-1 Month Momentum % | -93.07 | ||
| 52-Week Range ($) | 0.054 - 5.72 | ||
| Shares Outstanding (Mil) | 333.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
T2 Biosystems Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(TTOO)'s stock price today?
The current price of TTOO is $0.22. The 52 week high of TTOO is $5.72 and 52 week low is $0.05.
When is next earnings date of T2 Biosystems Inc(TTOO)?
The next earnings date of T2 Biosystems Inc(TTOO) is 2023-11-30 Est..
Does T2 Biosystems Inc(TTOO) pay dividends? If so, how much?
T2 Biosystems Inc(TTOO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers